Seeking Alpha

Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the...

Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the Irish biotech, which has a market cap of $1.6B, with AstraZeneca (AZN +0.4%) also in the hunt. Teva recently said it wasn't intending to make any major acquisitions, while it's also due to unveil a long-term overhaul in December.
Comments (3)
  • I'll believe it when I see it reported in a reliable news organzation's stories. Too long with nothing for now! But I'm a holder.
    15 Nov 2012, 09:56 AM Reply Like
  • teva alredy buy amarin.thay just wait until 11/12 to say that.
    15 Nov 2012, 01:04 PM Reply Like
  • How did you happen to acquire that juicy tidbit of information?
    15 Nov 2012, 01:23 PM Reply Like
DJIA (DIA) S&P 500 (SPY)